RxDoctor Payments Data

Susan Knoche, MD

Colon & Rectal Surgery · Summerville, SCNPI 1306013321

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (45.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 89.5% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $5,439, more than ten times the $310 reported in 2019.

$8,873in general payments, 2019–2025

Across 57 payments — averaging $155.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$8K
  • Avanir Pharmaceuticals, Inc.$145
  • Hollister Incorporated$128
  • KCI USA, Inc.$109
  • Medtronic$77
  • Smith+Nephew$72
  • plus $405 from 13 others

What the payments were for

  • Travel & lodging$3,33738%
  • Food & beverage$1,52717%
  • Education$4,00045%
  • Gifts$90%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical20$7,938
Avanir Pharmaceuticals, Inc.9$145
Hollister Incorporated1$128
KCI USA, Inc.1$109
Medtronic(2 entities)4$77
Smith+Nephew3$72
Neuraxis, Inc.1$58
Braintree Laboratories, Inc.2$46
Takeda Pharmaceuticals U.S.A., Inc.2$44
Johnson & Johnson2$42
Cook Medical LLC2$41
TELA Bio, Inc.3$40
Davol Inc.1$39
Innovation Technologies Inc1$28
Dermira, Inc.1$17
Axonics, Inc.1$15
Alfasigma USA, Inc.1$12
TEI Biosciences Inc1$12
Boehringer Ingelheim1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,873 in reported general payments places this provider in the 85th percentile of 35 colon & rectal surgery providers in South Carolina.

See all colon & rectal surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$87,680
Medicare patients
140
Services billed
335

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide15$7,926
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates26$1,707
Ondansetron OdtOndansetron24$139
Neomycin Sulfate22$114
Metronidazole24$49

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Summerville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →